DBPR108
DBPR108 is an orally active, dipeptide-based DPP4 inhibitor with an IC50 of 15 nM, demonstrating high selectivity as it does not inhibit DPP8 or DPP9. This compound is a valuable research tool for investigating DPP4 function in metabolic diseases, including diabetes, in both in vitro enzymatic assays and in vivo pharmacological studies.
Product Specifications
CAS Number
1186426-66-3
Product Name Alternative
Dipeptidyl Peptidase, DPP-4, DPP4, DPP, inhibit, Inhibitor, DBPR108, DBPR-108, DBPR 108
Field of Research
Protein Biochemistry
Purity
99.65% (May vary between batches)
Solubility
DMSO:≥ 25 mg/mL (77.07 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.17 mM)
Smiles
CC (C) (CC (=O) N1CCCC1) NCC (=O) N1C[C@@H] (F) C[C@H]1C#N
Molecular Formula
C16H25FN4O2
Molecular Weight
324.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MA5489-.05 50 µL
Anti-Transcription Factor 7 Like 1 Rabbit Monoclonal Antibody
Sign In for Pricing
View Details 
bsm-62464R-PE-Cy5.5 100 µL
ACAA2 Recombinant Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details RC231124L4 10 µg
RNF138 (NM_001191324) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
TP308360 20 µg
Ribonuclease Inhibitor (RNH1) (NM_002939) Human Recombinant Protein
Sign In for Pricing
View Details